• Je něco špatně v tomto záznamu ?

Local retrospective analysis of galactomannan cut-off values in bronchoalveolar lavage fluids for diagnosis of invasive aspergillosis

AP. Bellanger, H. Gbaguidi-Haore, N. Tatoyan, A. Berceanu, E. Scherer, L. Millon,

. 2018 ; 63 (6) : 757-761. [pub] 20180530

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19002816

Galactomannan antigen (GM) testing has been used for decades to screen immunocompromised patients for invasive aspergillosis (IA). Recent publications suggested that using a higher cut-off value than 0.5 in bronchoalveolar lavage fluid (BALF) could be more discriminant for hematology patients. We retrospectively analyzed the values of GM in BALF over 7 years (from 2010 to 2016). Performance indicators of the GM in BALF, according to three different cut-off values (0.5, 0.8, 1.5), were calculated using Stata 14.1. IA classification for hematology patients was based on European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria, as defined in 2008. A number of 716 GM were performed on BALF from 2010 to 2016 (597 patients) and 66 were positive (> 0.5). Among these 597 patients, 27 IA were diagnosed, 13 with a positive GM in BALF, 9 with a negative GM in BALF, and 5 unclassified IA (ICU patients). The analysis of performance indicators, based on our local data, did not demonstrate any significant difference using a higher cut-off value of GM in BALF. This result may be explained by the local recruitment of patients and by pre-analytic variations during BALF realization.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19002816
003      
CZ-PrNML
005      
20190116123306.0
007      
ta
008      
190116s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-018-0618-z $2 doi
035    __
$a (PubMed)29846912
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bellanger, Anne-Pauline $u Department of Parasitology-Mycology, Besançon University Hospital, Besançon, France. apbellanger@chu-besancon.fr. Chrono-Environnement CNRS 6249 Research Team, Franche-Comté University, Besançon, France. apbellanger@chu-besancon.fr.
245    10
$a Local retrospective analysis of galactomannan cut-off values in bronchoalveolar lavage fluids for diagnosis of invasive aspergillosis / $c AP. Bellanger, H. Gbaguidi-Haore, N. Tatoyan, A. Berceanu, E. Scherer, L. Millon,
520    9_
$a Galactomannan antigen (GM) testing has been used for decades to screen immunocompromised patients for invasive aspergillosis (IA). Recent publications suggested that using a higher cut-off value than 0.5 in bronchoalveolar lavage fluid (BALF) could be more discriminant for hematology patients. We retrospectively analyzed the values of GM in BALF over 7 years (from 2010 to 2016). Performance indicators of the GM in BALF, according to three different cut-off values (0.5, 0.8, 1.5), were calculated using Stata 14.1. IA classification for hematology patients was based on European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria, as defined in 2008. A number of 716 GM were performed on BALF from 2010 to 2016 (597 patients) and 66 were positive (> 0.5). Among these 597 patients, 27 IA were diagnosed, 13 with a positive GM in BALF, 9 with a negative GM in BALF, and 5 unclassified IA (ICU patients). The analysis of performance indicators, based on our local data, did not demonstrate any significant difference using a higher cut-off value of GM in BALF. This result may be explained by the local recruitment of patients and by pre-analytic variations during BALF realization.
650    _2
$a aspergilóza $x diagnóza $x metabolismus $x mikrobiologie $7 D001228
650    _2
$a Aspergillus $7 D001230
650    _2
$a biologické markery $7 D015415
650    12
$a bronchoalveolární lavážní tekutina $7 D001992
650    _2
$a lidé $7 D006801
650    _2
$a imunokompromitovaný pacient $7 D016867
650    _2
$a mannany $x metabolismus $7 D008351
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gbaguidi-Haore, Houssein $u Infection Control Department, Besançon University Hospital, Besançon, France.
700    1_
$a Tatoyan, Natacha $u Department of Parasitology-Mycology, Besançon University Hospital, Besançon, France.
700    1_
$a Berceanu, Ana $u Intensive Care Hematology Unit, Besançon University Hospital, Besançon, France.
700    1_
$a Scherer, Emeline $u Department of Parasitology-Mycology, Besançon University Hospital, Besançon, France. Chrono-Environnement CNRS 6249 Research Team, Franche-Comté University, Besançon, France.
700    1_
$a Millon, Laurence $u Department of Parasitology-Mycology, Besançon University Hospital, Besançon, France. Chrono-Environnement CNRS 6249 Research Team, Franche-Comté University, Besançon, France.
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 63, č. 6 (2018), s. 757-761
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29846912 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190116 $b ABA008
991    __
$a 20190116123518 $b ABA008
999    __
$a ok $b bmc $g 1367993 $s 1040974
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 63 $c 6 $d 757-761 $e 20180530 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
LZP    __
$a Pubmed-20190116

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...